Increased expression of tribbles homolog 3 predicts poor prognosis and correlates with tumor immunity in clear cell renal cell carcinoma: a bioinformatics study. Issue 5 (2nd May 2022)

• Record Type: Journal Article
• Authors: Wu, Xin-Qiang; Tian, Xi; Xu, Fu-Jiang; Wang, Yue; Xu, Wen-Hao; Su, Jia-Qi; Qu, Yuan-Yuan; Zhao, Jian-Yuan; Zhang, Hai-Liang; Ye, Ding-Wei
• Is Part Of: Bioengineered. Volume 13:Issue 5(2022)
• Page Start: 14000
• Page End: 14012
• Publication Date: 2022-05-02
• Subjects: TRIB3 -- ccRCC -- biological significance -- immune landscape characterization; Biomedical engineering -- Periodicals; Biotechnology -- Periodicals; Microbiology -- Periodicals; 660.6
• DOI: 10.1080/21655979.2022.2086380
• Languages: English
• ISSNs: 2165-5987

Abstract

ABSTRACT: Tribbles homolog 3 (TRIB3), a pseudokinase that regulates multiple intracellular signaling pathways, has been reported to promote the growth of multiple tumors. However, its role in clear cell renal cell carcinoma (ccRCC) remains unelucidated. We evaluated the role of TRIB3 in ccRCC using publicly available data from The Cancer Genome Atlas and analyzed its relationship with the tumor microenvironment; moreover, we used gene knockout and overexpression techniques to detect the effects of TRIB3 on the biological behavior of ccRCC cells. RT-qPCR and western blotting were used to detect transfection efficiency, and the invasiveness of ccRCC cells was determined by Transwell migration assays. We found that TRIB3 overexpression was significantly associated with increased grade, stage, and distant metastasis, positively correlated with ccRCC invasiveness, and also an independent risk factor for overall survival (OS). In addition, 361 differentially expressed genes (DEGs) related to TRIB3 were identified. Functional enrichment analysis showed that DEGs were mainly enriched in humoral immune responses, collagen-containing extracellular matrix, and serine hydrolase activity. Immune landscape characterization revealed that TRIB3 expression was significantly and negatively associated with CD8 + T and hematopoietic stem cells, whereas it was positively associated with NK T and macrophage M1 cells. Single-cell sequencing showed that localization and binding targets of TRIB3 mainly involved monocytes/macrophages and CD4 + and CD8 + T cells. Overall, our study revealed that elevated TRIB3 expression represents a promising prognostic marker for ccRCC patients and may play a key role in tumor microenvironment modulation. GRAPHICAL ABSTRACT: uf0001